These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
93 related items for PubMed ID: 272983
1. [Cardiotoxicity in long term treatment with cytostatics (author's transl)]. Fuhrmann U, Rieger M, Franz Ch. Dtsch Med Wochenschr; 1978 Mar 03; 103(9):387-90. PubMed ID: 272983 [Abstract] [Full Text] [Related]
2. [Cytostatic treatment as supplement in osteosarcoma and Ewing's sarcoma. Preliminary communication (author's transl)]. Krizan Z, Makai F, Krizan I, Blasková L, Látal J, Majeský B. Acta Chir Orthop Traumatol Cech; 1979 Feb 03; 46(1):26-8. PubMed ID: 88152 [No Abstract] [Full Text] [Related]
3. Noninvasive monitoring of adriamycin cardiotoxicity by "Sphygmo-Recording" of the pulse wave delay (QKd interval). Greco FA, Brereton HD, Rodbard D. Cancer Treat Rep; 1976 Sep 03; 60(9):1239-45. PubMed ID: 797446 [Abstract] [Full Text] [Related]
4. [Is the use of adriamycin (doxorubicin) limited by its cardiotoxicity?]. Reinhardt D, Hofmann V, Martz G. Schweiz Med Wochenschr; 1985 Apr 20; 115(16):557-61. PubMed ID: 4001904 [Abstract] [Full Text] [Related]
7. [The use and side effects of chemotherapy in the treatment of malignant bone tumors (osteosarcoma and Ewing's sarcoma) (author's transl)]. Prindull G, Poppe H, Fuchs K. Unfallheilkunde; 1979 Dec 20; 82(12):517-21. PubMed ID: 296860 [No Abstract] [Full Text] [Related]
11. [Cardiomyopathy after osteosarcoma treatment: a contribution to the cardiotoxicity of adriamycin]. Geidel S, Garn M, Grävinghoff L, Hausdorf G, Morf G, Bielack S, Knop J, Winkler K. Klin Padiatr; 1991 Dec 20; 203(4):257-61. PubMed ID: 1942931 [Abstract] [Full Text] [Related]
12. Second cancers in long-term survivors of Ewing's sarcoma. Smith LM, Cox RS, Donaldson SS. Clin Orthop Relat Res; 1992 Jan 20; (274):275-81. PubMed ID: 1729013 [Abstract] [Full Text] [Related]
13. [Myocardiopathy from a new anthracyclic derivative (author's transl)]. Montely JM, Gay J, Benoit P, Fontaliran F, Gerbaux A. Ann Med Interne (Paris); 1979 Dec 20; 130(12):709-14. PubMed ID: 539690 [Abstract] [Full Text] [Related]
14. [Changes in the T- and B-lymphocyte ratio in bone sarcoma patients before and after carminomycin treatment]. Vatin AE, Bizer VA. Antibiotiki; 1980 Nov 20; 25(11):864-7. PubMed ID: 6969572 [Abstract] [Full Text] [Related]
15. Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults. Kolb EA, Kushner BH, Gorlick R, Laverdiere C, Healey JH, LaQuaglia MP, Huvos AG, Qin J, Vu HT, Wexler L, Wolden S, Meyers PA. J Clin Oncol; 2003 Sep 15; 21(18):3423-30. PubMed ID: 12972518 [Abstract] [Full Text] [Related]
16. Radiation therapy in the multimodal management of Ewing's sarcoma of bone: report of the Intergroup Ewing's Sarcoma Study. Perez CA, Tefft M, Nesbit ME, Burgert EO, Vietti TJ, Kissane J, Pritchard DJ, Gehan EA. Natl Cancer Inst Monogr; 1981 Apr 15; (56):263-71. PubMed ID: 7029294 [Abstract] [Full Text] [Related]
18. Proceedings: Recent progress in the chemotherapy of primary tumors of bone. Gottlieb JA, Fernandez CH. Proc Natl Cancer Conf; 1972 Apr 15; 7():959-62. PubMed ID: 4587669 [No Abstract] [Full Text] [Related]
19. Unusual neuromuscular toxicity after treatment of bone sarcomas with adriamycin, vincristine, and cyclophosphamide. Sulis E. Cancer Treat Rep; 1978 Sep 15; 62(9):1408-9. PubMed ID: 278643 [No Abstract] [Full Text] [Related]
20. The evolution of chemotherapeutic agents for the treatment of pediatric musculoskeletal malignancies. Velez-Yanguas MC, Warrier RP. Orthop Clin North Am; 1996 Jul 15; 27(3):545-9. PubMed ID: 8649735 [Abstract] [Full Text] [Related] Page: [Next] [New Search]